Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 262.50% |
| Q2 2025 | 268.42% |
| Q1 2025 | 26.92% |
| Q4 2024 | 45.83% |
| Q3 2024 | -318.18% |
| Q2 2024 | 485.11% |
| Q1 2024 | -88.61% |
| Q4 2023 | 514.05% |
| Q3 2023 | -168.35% |
| Q2 2023 | 33.85% |
| Q1 2023 | 79.59% |
| Q4 2022 | -15.79% |
| Q3 2022 | 29.63% |
| Q2 2022 | 0.00% |
| Q1 2022 | -22.73% |
| Q4 2021 | 4.35% |
| Q3 2021 | -35.29% |
| Q2 2021 | 0.00% |
| Q1 2021 | 26.09% |
| Q4 2020 | -76.92% |
| Q3 2020 | -32.11% |
| Q2 2020 | 53.14% |
| Q1 2020 | -40.00% |
| Q4 2019 | -15.38% |
| Q3 2019 | 43.48% |
| Q2 2019 | -9.52% |
| Q1 2019 | 16.00% |
| Q4 2018 | -47.06% |
| Q3 2018 | 43.33% |
| Q2 2018 | -50.00% |
| Q1 2018 | -11.11% |
| Q4 2017 | 5.26% |
| Q3 2017 | -26.67% |
| Q2 2017 | 37.50% |
| Q1 2017 | -20.00% |
| Q4 2016 | 44.44% |
| Q3 2016 | -140.00% |
| Q2 2016 | -7.14% |
| Q1 2016 | 33.33% |
| Q4 2015 | -16.67% |